CONFERENCE AND EXHIBITION€¦ · CONFERENCE AND EXHIBITION Technology Innovations, Improving...

WWW.ISPESINGAPORE.ORG

ISPE Singapore Affiliate Conference and Exhibition 2020 will be a virtual event

With immersive virtual broadcasting and networking, this event will be accessibleto pharma industry stakeholders globally.

600+PARTICIPANTS

65+SPEAKERS

25+COUNTRIES

3DAYS

CONFERENCE AND EXHIBITIONTechnology Innovations, Improving Healthcare

9 - 11 December 2020 I Virtual Conference

QUALITY & COMPLIANCE

COVID-19 MARKET SCENARIOS

INDUSTRY-REGULATOR

COLLABORATION

DATA INTEGRITY & GAMP

TECHNOLOGY DEVELOPMENT IN MANUFACTURING

INNOVATIONS IN DIGITAL PHARMA

REGULATORY AND COMPLIANCE

POST CONFERENCE:

BEST PRACTICES & TECHNOLOGY

SYMPOSIUMTOPICS COVERED IN 2020

DELIVERED DIGITALLY

Organised by:

http://www.ispesingapore.org


CONFERENCE AND EXHIBITION

AGENDA AT A GLANCE:

ABOUT THE CONFERENCEISPE Singapore Affiliate Conference and Exhibition 2020 will be a fully virtual event. You will experience a high-quality live stream of the event, that promises all the content as well as virtual networking options. Join and interact in live discussions, catch up on sessions you missed or watch again after the event.

With a record 1000+ participants, the ISPE Singapore Affiliate Conference and Exhibition broke new ground in 2019. We saw a strong presence of Pharma and Manufacturers, supported in equal measure my Regulators, EPCM, and various other stakeholders and service providers.

TRACK 1 TRACK 2 TRACK 1 TRACK 2

#INTERACTIVE LIVE CHATS AND DISCUSSIONS

TECHNICAL DIGITAL THEATERS

PRE EVENT ROUNDTABLE DISCUSSIONS

WORKSHOPS

REGULATOR KEYNOTE:PIC/s Inspection Reliance and Desktop Inspections

PLENARY PANEL DISCUSSION:Pandemic Crisis Response: Ensuring the Cure Isn’t Worse

than the Disease

KEYNOTE ADDRESS:Embracing the Digital Pharma Factory of Tomorrow

PANEL DISCUSSION:Reaching Digital Maturity

through Pharma 4.0

Regulatory & ComplianceTechnology Developments

in Manufacturing

Regulatory & Compliance Innovations in Digital Pharma Regulatory & Compliance Technology Developments

in Manufacturing

Data Integrity Technology Developments

in Manufacturing

PRE-CONFERENCE ACTIVITIES

DAY 1 9TH DEC 2020

DAY 2 10TH DEC 2020

DAY 3 11TH DEC 2020

TRACK 1 TRACK 2JOINT OPENING PLENARY SESSIONS JOINT PLENARY SESSIONS

Virtual Conference Highlights:Gain access to unique live content across three days along with quality networking and matchmaking opportunities!

60+ VIRTUAL LIVESTREAM SESSIONS: Hear from global market experts and plan your participation with a virtual agenda, customisable to opt into panels and presentations across the three days.

QUALITY NETWORKING:With intent based and AI powered virtual matchmaking, you will meet quality leads over 1:1 meetings to make meaningful connections.

ON DEMAND CONTENT:We will provide full access for you to view our quality content on demand for up to three months after the event so you don’t miss out on any session.

VIRTUAL EXHIBITION:A virtual showcase of players in the industry for you to view product demos, network and take your business to the next level.


https://www.ispesingapore.org/pricing/


STELLAR LINE-UP OF GLOBAL PHARMA MANUFACTURERS AND EXPERTS

SPONSORS AND EXHIBITORSKey SponsorAssociate

SponsorSponsor Track Sponsor Exhibitors

David Churchward Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP Inspector) MHRA, UK

Chong Hock Sia Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group Health Sciences Authority, Singapore

Sook Peng Chua ASEAN Regulatory and Quality Compliance Director Johnson and Johnson (J&J), Singapore

Anchalee Anuchitanukul Head of Compliance, Pharmaceuticals, Country Compliance Head Novartis, Thailand

Pakhi Rusia Director of Global Regulatory Affairs GSK, Singapore

Ewelina Markuszewska Quality Control Expert DaviPharm (Adamed Group), Vietnam

Lam Quang Nhat Quality Assurance, Pharmacovigilance, Regulatory Affairs Executive Daiichi Sankyo Co., Ltd., Vietnam

Hazem Eleskandarani Project Director, Engineering & Property Services Johnson & Johnson, United States

Dr. Faseeh Abdus Salam Production Head FAAS Pharmaceutical Pte. Ltd., Pakistan

Dasarathi KKC Head of Regulatory Affairs (API) Aurobindo Pharma, India

Roger Harty Director of EMEA & APAC AstraZeneca, Belgium

Samme Wang Head of Engineering and Technology Asia Bayer, Singapore

James Wu Chief IT Officer Roche, Taiwan

Rajnish Narula Director Business Excellence Pfizer, Singapore

Rajesh Thempadiyil Business Process Excellence & CoE Lead Dr. Reddy’s Laboratories Ltd., India

Ahmed Abdel Rahman Bashtar Regional QA Compliance Head Julphar, United Arab Emirates

Meidi Fransisca Siregar IT Manufacturing Lead PT Bayer Indonesia

Ewan Dowie Head of Production Ego Pharmaceuticals, Australia

Raneeth Reghu Head of Procurement Biocon Biologics, Malaysia

Minh Tran Chief Operating Officer Stelis Biopharma, India

Dr. Anthony Deodaunia William Senior Manager Technical Operations- API Manufacturing AbbVie, Singapore

Shailendra Singh Bhadoria Head- Manufacturing and Sciences Oncogen Pharma, Malaysia

Md. Zakar Executive Director, Plant Operations NIPRO JMI Pharma Ltd., Bangladesh

Ahmad Fikri Hasim Head of Production Ain Medicare Sdn Bhd, Malaysia

Taufik Muhammad Engineering Compliance Expert Novartis, Singapore




WEDNESDAY, 9 DECEMBER 2020: DAY 1

14:40 Online Networking & Stretch Break

18:30 End of Virtual Conference Day 1


13:00 Welcome RemarksShanshan Liu, President, ISPE Singapore Affiliate

13:10 Opening AddressFran Zipp, International Board Chair, ISPE, & Chief Executive Officer, Lachman Consultant Services, United States

13:20 The Impact of COVID-19 on Government Investments & Partnerships in Healthcare InnovationSenior Representative from Singapore’s Economic Development Board

13:40 ASEAN MRA Update and International Reliance Programs• Future ASEAN developments on pharmaceutical inspections • Singapore’s partnerships in MRAs and reliance in pharmaceutical inspection and regulation Chong Hock Sia, Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group, Health Sciences Authority, Singapore

14:10 Update on ICH-Q13 Dr. Yoshihiro Matsuda, Senior Scientist (for Quality) PMDA, & Regulatory Chair, ICH-Q13, Japan

JOINT OPENING PLENARY SESSIONS

REGULATORY & COMPLIANCE:Chairperson: Robert Tribe, Asia-Pacific Regulatory Affairs Advisor, ISPE

INNOVATIONS IN DIGITAL PHARMA

16:00 REGULATOR KEYNOTE: PIC/s Inspection Reliance and Desktop Inspections Anne Hayes, Inspection Manager, Health Products Regulatory Authority, Chairman, Pharmaceutical Inspection Co-operation Scheme (PIC/S), Ireland

16:30 PANEL DISCUSSION: Industry-Regulator Collaboration • Training • Regulatory document reviews • Identification of emerging problems

Moderator: Vasiliki (Vee) Revithi, Ex-Head, GMDP Inspectorate, EOF Medicines Agency of Greece

Panellists: Sook Peng Chua, ASEAN Regulatory and Quality Compliance Director, Johnson and Johnson (J&J), Singapore Chong Hock Sia, Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group, Health Sciences Authority, Singapore Dr. Georg Singewald, VP, Head of Global Quality Control, Genentech, United States Anne Hayes, Inspection Manager, Health Products Regulatory Authority, Chairman, Pharmaceutical Inspection Co-operation Scheme (PIC/S), Ireland

17:15 Brexit UpdateDavid Churchward, Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP Inspector), MHRA, UK

17:45 PLENARY PANEL DISCUSSION: Pandemic Crisis Response: Ensuring the Cure Isn’t Worse than the Disease • Drug shortages • Regulating for expedited trials and approvals • Balancing ethical processes vs speed to

market • Maintaining risk and compliance while

scaling agile • COVID 19: Lessons learned in effective global

co-operation in times of crisis

Moderator: Robert Tribe, Asia-Pacific Regulatory Affairs Advisor, ISPE Panellists: David Churchward, Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP Inspector), MHRA, UK Dr Yoshihiro Matsuda, Senior Scientist (for Quality) PMDA, & Regulatory Chair, ICH-Q13, Japan Anne Hayes, Inspection Manager, Health Products Regulatory Authority, Chairman, Pharmaceutical Inspection Co-operation Scheme (PIC/S), Ireland

15:10 Significance of Digitalisation in Operations and Usage of Pharma 4.0 for Accelerating the Same • What we learned from lock down conditions • Business Continuity Plan during COVID 19 • Change in operations strategy after COVID19 Rajesh Thempadiyil, Business Process Excellence & CoE Lead, Dr. Reddy’s Laboratories Ltd., India”

15:40 Technologies Reshaping the Future of the Pharma Industry • History of the tech revolution and its link to

the pharma industry • Remaining barriers to tackle • Top technological approaches to use in

pharma • Examples of newly-applied tech in therapies

like personalised medicine Ahmed Abdel Rahman Bashtar, Regional QA Compliance Head, Julphar, United Arab Emirates

16:10 Technology Innovation for the Future James Wu, Chief IT Officer, Roche, Taiwan

16:40 State of IT Security in Pharma Manufacturing • Background of pharma manufacturing IT

security • Pharma industry risks and treats • Industry trends and their impact on security • Gaps analyses and best practices

Meidi Fransisca Siregar, IT Manufacturing Lead, PT Bayer Indonesia

17:10 Flexible and Smart Production of Tomorrow’s Medicines • The healthcare sector is facing tremendous

changes• Novel Cell & Gene Therapies such as CAR-T

conquer the market• Pharmaceutic production methods change

radically• Flexible plants for prudent CAPEX decisionsDr. Stefan Kappeler, Technology Manager Life Sciences, Exyte, Switzerland




THURSDAY, 10 DECEMBER 2020: DAY 2

17:15 KEYNOTE ADDRESS: Embracing the Digital Pharma Factory of Tomorrow • AstraZeneca’s current digital factories initiative strategy• How the factories of the future will bring about change• How to successfully imbed this change in the organizational cultureRoger Harty, Director of EMEA & APAC, AstraZeneca, Belgium

17:45 PANEL DISCUSSION: Reaching Digital Maturity through Pharma 4.0 • Applying Big Data, information systems and digital tech in pharma manufacturing• Life cycle management for organisation and process• Major issues and success factors facing digital transformation• Communication and decision making driving cultural change

Moderator: Pierre Winnepenninckx, Conference Chair, ISPE Singapore Affiliate & Chief Executive Officer, No Deviation Pte. Ltd.

Panellists: Roger Harty, Director of EMEA & APAC, AstraZeneca, Belgium James Wu, Chief IT Officer, Roche, TaiwanSamme Wang, Head of Engineering and Technology Asia, Bayer, Singapore Rajnish Narula, Director Business Excellence, Pfizer, Singapore “

JOINT CLOSING PLENARY SESSIONS

REGULATORY & COMPLIANCEChairperson: Fran Zipp, International Board Chair, ISPE, & Chief Executive Officer,

Lachman Consultant Services, United StatesTECHNOLOGY DEVELOPMENTS IN MANUFACTURING

13:00 Compliance Monitoring: A Health Check-Up Tool and its Importance • What is compliance monitoring and why is it

crucial?• Challenges & techniques to improve

monitoring to anticipate and mitigatecompliance risk

Anchalee Anuchitanukul, Country Head Ethics, Risk and Compliance, Novartis, Thailand

13:30 Quality by Design during Product Development & Beyond Pakhi Rusia, Director of Global Regulatory Affairs, GSK, Singapore

14:00 Transitioning of EU GMP and Adapting Entry into Emerging Markets • Some regulatory characteristics of the

Vietnamese Drug Administration (DAV)• How harmonized are the different

international standards on drug production(ASEAN GMP, WHO GMP, EU GMP)? *Compliance and data integrity challenges inVietnam, and lessons learnt

Ewelina Markuszewska, Quality Control Expert, DaviPharm (Adamed Group), Vietnam

14:30 Managing Regulatory Compliance in Vietnamese Pharma Market • Impact of the new Decree 155 on regulatory

compliance• Considerations to align your Big Pharma

regulatory strategy to the local market• Inspection Readiness: what to expect and

how to prepareLam Quang Nhat, Quality Assurance, Pharmacovigilance, Regulatory Affairs Executive, Daiichi Sankyo Co. Ltd., Vietnam

15:00 Myanmar Pharma Industry View on ASEAN GMP • Updates on ASEAN MRA on GMP• Compliance with ASEAN GMP• Meeting data integrity requirements in

MyanmarChandrakant Bhandare, Head of Quality, Zydus Cadila Myanmar

15:30 Building the External Supplier Relationship: Ensuring a Safe, Compliant and Productive Supply Chain• Compliance expectations for both the MAH

Holder and the CMO/Lab• Quality Agreements – what they need to

include• Supply Agreements – how they can aid the

relationship• MAH oversight and staffing needs – many

companies understaffBeth Haas, Principal Consultant / Senior Project Manager, CAI, USA

16:00 ICH Q12 Case Studies:

Case Study: Using Established Conditions to Facilitate Post-Approval Regulatory ChangesConnie Langer, Regulatory Strategist, Pfizer, United States

AstraZeneca’s Experience with the FDA Pilot & Preparation for Subsequent Implementation in Other RegionsFrank Montogomery, Global Head, Regulatory CMC, AstraZeneca, United Kingdom

The Journey Towards Regulatory Convergence in Product Life Cycle Management: ICH Q12 and BeyondNina Cauchon, Director, Amgen, United States

13:00 Leadership, Lean Manufacturing and Pharma 4.0 Ewan Dowie, Head of Production, Ego Pharmaceuticals, Australia

13:30 Pharmaceutical Water Systems• Cost effective WFI generation by Vapor

Compression Distillation• Vapor Compression Vs Traditional Multi

Effect DistillationDr. Louis Hon, Technical Sales Manager, MECO Water Purification Pte Ltd, Singapore

14:00 The Role of Design of Experiments in the Product Lifecycle Management • Product Lifecycle management fundamentals

and stages of product realization• Key elements of quality by design (QbD)• Design of Experiment as a powerful

technique of QbD & Process Optimization• Practical considerations for implementing

compression profiling & Design ofExperiment for Oral Solid Dosage Forms

Alfonso Quiros, New Product Introduction & Technical Head, Site Leadership Team Kuala Lumpur, CHSC Asia Pacific, GSK, Malaysia

14:30 Re-thinking Business Resiliency in Life Sciences 4.0Cyber-attacks or the threat of disruption to production are happening more frequently than ever. Business Agility has been challenged under such circumstances and it’s critical to put in place resiliency frameworks/technologies to recover business service, especially where companies strive to avoid a disruption in their supply to the market.

Joint Presentation:Claire Tran, Project Manager, Zenith, SingaporeLay Peng Tan, IT Manager, AbbVie Singapore Manufacturing

15:00 High Containment using Single Use Systems for HPAPI Manufacturing• Containment examples for reactor charging,

centrifuge off loading, dryer charging /discharging, and conical milling processes

Scott Patterson, Vice President Pharma / BioPharma Technical Support, ILC Dover, USA

15:30 Improving Energy Efficiency in Pharmaceutical Manufacturing Taufik Muhammad, Engineering Compliance Expert, Novartis, Singapore

16:00 Trends and Technology in Modern Aseptic Processing • Current trends and challenges in final fill• Regulatory overview• Key considerations for contained

manufacturing to ensure patient safetyAshok Kumar, Single Use Bioprocessing Regional Manager - India and Southeast Asia, Merck Life Science, India


“The ISPE conference is an excellent way to get energised to deliver value to my organization. I f eel confident in the implementation of concepts I learnt here”.Catherine Le Denmat, Associate Engineer, MSD



16:30 Considerations for an Industry 4.0Vaccine National Platform • State of vaccine self-sufficiency & impact of

COVID-19 pandemic• Snapshot of latest innovations in

manufacturing technology for vaccinesindustry 4.0

• Considerations for different expressionplatforms for producing vaccine drugsubstances & manufacturing technologies

• New drug delivery systems & formatsexplored

Xiangliang Lin, Founder,President & CEO, Esco Aster, Malaysia




FRIDAY, 11 DECEMBER 2020: DAY 3



17:30 End of Virtual Conference Day 3 18:15 End of Virtual Conference Day 3

REGULATORY & COMPLIANCE: TECHNOLOGY DEVELOPMENTS IN MANUFACTURING

13:00 PANEL DISCUSSION: Regulatory Compliance in Emerging Markets Moderator: Alfonsus Karli, APAC GCMC Advisory Office Director, Pfizer Pte Ltd & ISPE Singapore Affiliate Vice Chair, Regulatory Affairs Panellists: Anchalee Anuchitanukul, Country Head Ethics, Risk and Compliance, Novartis, Thailand Chandrakant Bhandare, Head of Quality, Zydus Cadila Myanmar Ewelina Markuszewska, Quality Control Expert, DaviPharm (Adamed Group), Vietnam Chong Hock Sia, Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group, Health Sciences Authority, Singapore

13:45 Implementing and Complying with International cGMPs in Pakistan’s Pharma Industry• Overview of regulatory framework and

national pharma manufacturing industry inPakistan

• Major challenges confronting the industry• Importance of cGMP to combat quality issues

in pharma: Identity, quality, strength & purityof drug

• Proper design, monitoring and control onmanufacturing process and facilities

Dr. Faseeh Abdus Salam, Production Head, FAAS Pharmaceutical Pte. Ltd., Pakistan

14:15 Changing Regulatory Landscape and Current Challenges for the API Industry• Areas of regulatory changes from past years

to recent• New trends in regulatory enforcement in life

sciences• New requirements to reduce audit

compliance risk in the current scenario• Regulatory compliance through real data

managementDasarathi KKC, Head of Regulatory Affairs (API), Aurobindo Pharma, India

14:45 Understanding Regulatory Requirement on Cleaning and Disinfection• Cleaning and Disinfection. Debunking the

myth.• Regulatory expectations – Draft Annex 1, FDA

and PIC/S• How to demonstrate compliance to

inspectorsRichard Chai, Technical Service Manager, STERIS Corporation, Singapore

13:00 Sourcing Challenges and Imperatives in the Biologics Space • Current state of end-end manufacturing

processes for biologics• Challenges specific to manufacturing

biologics• Best practices in vendor managementRaneeth Reghu, Head of Procurement, Biocon Biologics, Malaysia

13:30 CASE STUDY: Lean CapEx Project Delivery to Support Patients in Asia-Pacific • Importance of capital-expenditure

management in pharma• How does lean help to maximize CapEx

benefits and patient-centricity?• Project Management team:

• Project methodology• Externalisation• Talent development

Samme Wang, Head of Engineering and Technology Asia, Bayer, Singapore

14:00 Isolators for Pharmaceutical Manufacturing Shailendra Singh Bhadoria, Head- Manufacturing and Sciences, Oncogen Pharma (Malaysia)

14:30 CLEANING VALIDATION & VERIFICATION CASE STUDY: • From Initial Tech Transfer from API to

Commercial ManufacturingDr. Anthony Deodaunia William, Senior Manager Technical Operations- API Manufacturing, AbbVie, Singapore

DATA INTEGRITY

15:30 Data Integrity Compliance and Key to Reduce Data Integrity Violation TrendsShantha Kumara, Quality Assurance Manager, Strides Pharma, Singapore

16:00 Statistical Techniques for Product Quality Improvement & Monitoring• Importance of applying statistical thinking to

quality improvement• Overview of practical and simply statistical

methods used for quality improvement• Practical and statistical considerations when

choosing a statistical method to useMd. Zakar, Executive Director, Plant Operations, NIPRO JMI Pharma Ltd., Bangladesh

16:30 Developing a Robust Quality System to Assure Data Integrity• Regulatory trends and guidance in

Philippines’ pharma industry• How data integrity and process monitoring

are critical to each other for regulatorycompliance

• Link between data integrity and qualityculture

• Remaining pain-points in data integrityCloyd Lambojon, Supervisor Production / Site Data Integrity Lead, GSK, Philippines

17:00 Merging Laboratory and Manufacturing Data• This presentation will give an introduction

to digital sensor technologies and resultingbenefits and capabilities.

• The merging of laboratory and manufacturingdata is shown based on a practical example.

Dr Michael Weiss, Product Management, Endress+Hauser Conducta GmbH+Co. KG, Germany

15:30 Key Considerations for Successful Implementation of Single Use Systems in Final Filling of Drug Products Minh Tran, Chief Operating Officer, Stelis Biopharma, India

16:00 Time for Integrating Excellence Models in Pharma • Visual management• Data-driven performance management• Systematic process for generating and

implementing continuous improvementsRajnish Narula, Director Business Excellence, Pfizer, Singapore

16:30 Basic Considerations and Implementation of Track and Trace in Pharma Manufacturing • Regulatory environment and global

requirements • Benefits of track and trace system to the

pharma industry• Key elements of a successful track and trace

system• Challenges in implementing track and trace

technologyAhmad Fikri Hasim, Head of Production, Ain Medicare Sdn Bhd, Malaysia

17:00 Planning & Executing a Successful Project• Definition of a successful project• Elements of a successful project

• Project Charter• Team Structure• Project Planning• Execution Stage• Project Close Out

• Project Management challenges in thepharmaceutical industry

Hazem Eleskandarani, Project Director, Engineering & Property Services, Johnson & Johnson, USA

17:30 PANEL DISCUSSION: Lean Manufacturing Operations – Achieving More with Less • Strategies to achieving pharma operational

excellence • Best practices to optimise flexible and agile

production`• Reducing waste, maximising productivityModerator: Hazem Eleskandarani, Project Director, Engineering & Property Services, Johnson & Johnson, USA

Panellists: Minh Tran, Chief Operating Officer, Stelis Biopharma, India Dr. Anthony Deodaunia William, Senior Manager Technical Operations - API Manufacturing, AbbVie, Singapore Meidi Fransisca Siregar, IT Manufacturing Lead, PT Bayer Indonesia Ahmad Fikri Hasim, Head of Production, Ain Medicare Sdn Bhd, Malaysia




Dear industry colleagues,

COVID-19 has shaken up industry operations as pharmaceutical manufacturing leaders are rallying to accelerate processes to bring about key medicines across borders. As the industry transforms at rigorous speed; learning developments for technical and commercial best practices are being continually refined in all aspects of manufacturing.

ISPE Singapore Affiliate’s annual conference is pleased to once again offer you a learning and networking opportunity like no other in Singapore. The 2020 edition will be fully virtual.

You will experience a high-quality live stream of presentations, dedicated discussions, virtual networking options during the event, and on-demand content is available up to 3 months after the conference.

2019 attracted a record 1000+ participants, the ISPE Singapore Conference and Exhibition broke new ground in 2019. We saw a strong presence of Pharma and Manufacturers, supported in an equal measure by Regulators, EPCM, and various other stakeholders and service providers. We hope to see more participation as a hybrid conference format opens more opportunities for the global community to log on and learn.

As above, industry support by itself is our testament to the quality, and we promise an even better, newer, and value-packed event experience for your benefit.

Do make the time to attend with your teams. I am confident it will generate great learning value for your organisation.

I look forward to meeting you in December, online.

With regards,

Pierre WinnepenninckxChairISPE Singapore Conference 2020




10,000+Contacts

Email Outreach

75,791LinkedIn

Impressions

12,438Unique Website Visitors from 112

Countries

MAKE AN INVESTMENT INTO YOUR COMPANY’S FUTURE WITH OUR DIGITAL SPONSORSHIP AND EXHIBITION PACKAGES

To discuss opportunities for raising your brand profile Contact: Yvonne Leong

T: +65 6508 2489 E: [email protected]

Sponsorship OpportunitiesSponsoring a part of the ISPE Singapore Conference & Exhibition allows companies to target key decision makers in the international pharma manufacturing industry.

• Create company exposure

• Strengthen your brand position

• Reinforce relationships

• Raise your profile before, during and after the event

25+Trade Media and Industry Association

Partners

THOUGHT LEADERSHIP

Offer keynotes and educational sessions to you audience through

live webinars or pre-recorded video broadcast with automated reminders, Q & A sessions and polls to keep your

attendees engaged.

INFORMA DATA+

Unique option for increased lead generation through retargeting of our global proprietary database in social

media

POWERFUL DIGITAL MATCHMAKING

Build valuable relationships with our intelligent matchmaking tool, live chat

and integrated 1:1 video calls.

VIRTUAL BOOTHS

Online spaces with your brand identity, showcase your product demos, live

chat with audiences. Manage your own logo, description video, collateral, staff

profiles and more.

FOCUSED METRICS

Measurable exposure and trackable meetings generate great ROI. Booth

views, meeting requests, engagement rates – you’ll have all the data you need

ACCELERATED BRAND EXPOSURE

Gain prominence with focused digital theatres in the lead up, main

conference days, and up to 3 months after the event with our on-demand

content modules

OUR MARKETING OUTREACH!



P46412

Special Corporate Rate: Register 50 delegates: SGD $8895

ISPE Member – Please provide ISPE membership ID during registration

FEE PER DELEGATEEarly Bird RateRegister & pay before 31 October 2020

Normal RateRegister & pay after 31 October 2020

Group Rate(per person, 3 or more delegates)

Live Online Experience (Per delegate) $600 $700 $600

Non ISPE Member BECOME A MEMBER

FEE PER DELEGATE (SGD)Early Bird RateRegister & pay before 31 October 2020

Normal RateRegister & pay after 31 October 2020

Group Rate(per person, 3 or more delegates)

Live Online Experience (Per delegate) $750 $850 $750

Government, Academic & Emerging Markets Rate

Live Online Experience (Per delegate) $300

Special Group Rates for Pharma Companies

Live Online Experience (Per delegate) $500

REGISTRATION

3 EASY WAYS TO REGISTERContact Miki Kong+65 6508 2477

Registration Enquiry [email protected]

Websitewww.ispesingapore.org

1. For cancellation/substitution terms & conditions, please visit: https://www.informaconnect.com.sg/terms/

2. Informa Connect is a trading name of IBC Asia Pte Ltd Informa Connect

*ISPE Singapore Affiliate Conference And Exhibition 2021 will be back to a physical event, please stay tuned for more 2021 updates

9-11 December 2020Virtual Conference

CONFERENCE AND EXHIBITION

https://ispe.org/membership/join

https://www.informaconnect.com.sg/terms/


CONFERENCE AND EXHIBITION€¦ · CONFERENCE AND EXHIBITION Technology Innovations, Improving...

Documents

Transcript of CONFERENCE AND EXHIBITION€¦ · CONFERENCE AND EXHIBITION Technology Innovations, Improving...